All filters
Abstracts
Mortality after loss to follow-up - a linkage study of people living with HIV in Thailand and Malaysia
A. Jiamsakul Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Impact of COVID-19 pandemic on HIV care delivery and access in Asia
T. Wong Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Impact of the COVID-19 Pandemic on HIV Services in Taiwan: Results from a Cross-sectional Online Survey
W. Liu Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
HIV Integrated Care Unit for Allied Health Services (The HERCULES Project) in a community-based organization, Malaysia
C. Chang Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
A Cross-sectional Study Examining Sexual Health and Health seeking Behavior using LINE survey across Japan
H. Hoshino Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Amphetamine-type stimulant use is common and associated with HIV infection among MSM and TGW in Bangkok, Thailand
D. Colby Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Pediatric disclosure of HIV status and effect on mortality and LTFU among children and adolescents living with HIV in Asia
J. Sornillo, Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Psychosocial Risk Factors and Cognitive Decline in People Living with HIV: Results from the Malaysian HIV and Aging (MHIVA) Study
M. Neelamegam Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Self-sampled specimens demonstrate comparable sensitivity and specificity to clinician-sampled specimens for HPV detection among MSM in China
Y. Lu Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfected Patients Through 96 Weeks
Y Huang Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Toward Hepatitis B and hepatitis D elimination in Cuba
L. Lay Rodriguez  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Occult Hepatitis B Virus Infection among HIV negative and positive isolated anti-HBc individuals in Eastern Ethiopia
D. Ayana  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Healthcare consumption in addicted versus non-addicted hepatitis B and C patients in the Netherlands
D. Von Den Hoff Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence and associated risk factors for Hepatitis B virus infection among barbers and their clients in two cities of Cameroon
N. Joël Brice Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA seroconversion and genetically linked HCV infections
P. Mateu-Gelabert  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Cost Effectiveness of expanding treatment with Direct Acting Antiviral treatment to reduce Hepatitis C incidence among HIV infected MSM in Thailand
S. Mukherjee Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Missed Opportunities for HCV Elimination in Provincial Correctional Institutions in Ontario, Canada
P. Ioudovski Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Reduction of hepatitis C burden in Islamabad, Pakistan slums through CHW screen and treat programs
H. Mahmood  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
HCV elimination in France. The countdown has started
V. de Ledinghen  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Models of Care: Strategies towards Elimination of Hepatitis C in Iceland
R. Fridriksdottir  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
The TREAT-B score predicts disease progression in Ethiopian patients with chronic hepatitis B
A. Johannessen Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Expression of HBV-infection markers in placenta of women with chronic hepatitis B
M. Belopolskaia  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020